People In Brief
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed board: Edwards Lifesciences CEO Michael A. Mussallem officially took the role of chairman of AdvaMed's board of directors March 13 at the association's annual meeting in La Quinta, Calif. He succeeded Becton Dickinson CEO Edward J. Ludwig. Mussallem has chaired the board's payment and health care delivery committee for the past two years and previously headed the international committee. AdvaMed also named Beckman Coulter CEO Scott T. Garrett chair of the technology and regulation committee, Medtronic CEO William Hawkins chair of the payment committee and Advanced Medical Optics CEO James V. Mazzo chair of the board's international committee
You may also be interested in...
FDA Panel Backs Testing Of Concurrent And Sequential Mammography CAD
FDA should require sponsors of computer-aided detection for mammography to test their devices with both sequential and concurrent reading approaches, FDA's Radiological Devices Advisory Panel recommends
Parkinson’s Results Further Sweeten AbbVie’s Acquisition of Cerevel
Cerevel, which AbbVie is spending $8.7bn to acquire, unveiled topline results from the TEMPO-3 study of tavapadon, which an analyst said represents potentially a $1bn opportunity.
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.